MAPP students gain valuable experience that they will be able to take the next level upon their graduation. Houston Methodist graduate nurses participate in our nurse residency program, which also includes the only Texas Medical Center University Health. System Consortium (UHC) Nurse Residency Program. The internship is geared toward further developing clinical skills, while the residency side of the program works on leadership and professional growth. Experienced nurses also have the opportunity to continue their education through a variety of programs, including internships, leadership seminars, continuing education classes, and a number of additional learning opportunities: No matter what your experience level is as a nurse, Houston Methodist is committed to working with you to enhance your career and continue your professional growth. We are leaders in nursing, we are leading medicine. These mentors guide and support the resident nurse.UAB Hospital has an RN Internship program. Children's Hospital is beginning an Internship program, I've heard.and I think that maybe St. UAB hiring new graduates. UAB wants to know that you really want to work. University of Alabama at Birmingham. University of Alabama at Birmingham – Nurse. Program Nurse Residency nurse residency program Nurse Residency Programs. Give to UAB; Research Administration; UAB eLearning; More Items. Crowdfunding at UAB; Matching Gift Program; Donor Bill of Rights; News. Publications; Videos; Get. VUMC's Nurse Residency Program. VUMC created a Nurse Residency Program to help newly hired nurse graduates transition into the role of professional nurse. UAB's Epilepsy Fellowship Program. Completion of a neurology residency program in the United States or Canada and full. UAB - SOM - Department of Pediatrics. Kimberly Whelan, M. D., MSPHAssociate Professor of Pediatrics. Acting Division Director. Director, TLC clinic and Childhood Cancer Survivors Program. Director, Hem/ Onc Fellowship Program. Dr. Whelan is a graduate of the University of South Carolina's School of Medicine. She completed her pediatric residency at Vanderbilt University Medical Center and later her fellowship in pediatric hematology and oncology here at UAB. She is currently the Medical Director of the TLC clinic. The focus of her research is the late effects of cancer therapy. Elizabeth Alva, M. D. Assistant Professor. Christy Bemrich- Stolz, M. D. Assistant Professor. Dr. Bemrich- Stolz is an Instructor in the UAB Division of Pediatric Hematology- Oncology. Bemrich- Stolz’s clinical practice includes general hematology and oncology though she does have a particular interest in caring for patients with sickle cell anemia. Bhatia's current focus is to establish a comprehensive program for cancer outcomes and survivorship research at UAB. This program will reduce the burden of cancer and its sequelae across all segments of the population through collaborative interdisciplinary, interventional and educational efforts in Pediatrics and other Departments. Bhatia is an elected member in the American Society for Clinical Investigation. Joseph Chewning, M. D. Associate Professor of Pediatrics. Blood and Marrow Transplantation Program. Dr. Chewning is a graduate of Davidson College and the University of South Carolina Medical School. After completing a pediatric residency and a chief residency year at Erlanger Hospital in Chattanooga, he trained in pediatric hematology- oncology at Memorial Sloan- Kettering Cancer Center. Chewning remained at Memorial Sloan- Kettering where he did an additional fellowship in bone marrow transplantation while performing human Natural Killer Cell research. Chewning's research focus is translational studies for the prevention and treatment of graft versus host disease. Chewning is developing novel mouse models exploring the role of CD4+ T cell lineages in mediating graft versus host disease. Chewning is also designing clinical research protocols for mechanisms of chronic graft versus host disease in pediatric patients undergoing hematopoietic stem cell transplantation. Stuart Cramer, D. O. Assistant Professor. Dr. Cramer is a graduate of the University of Florida and attended Nova Southeastern College of Osteopathic Medicine in Ft. Lauderdale Florida for medical school. Cramer is interested in cancer cell biology, specifically chemotherapeutic drug resistance. Mary- Ann Bjornsti, chair of the Department of Pharmacology and Toxicology, investigating the experimental drug MLN 8. Aurora A kinase inhibitor in neuroblastoma. Cramer received research funding from the St. Baldrick’s Foundation allowing him to explore the role drug transporters play in neuroblastoma drug resistance, and has been granted an extra year of funding by the foundation. Cramer hopes that a better understanding of cancer cell resistance will improve outcomes in hard to treat pediatric cancers. Gregory Friedman, M. D. Friedman is a graduate of the College of William and Mary and the Medical College of Georgia. His primary interests are pediatric neuro- oncology and conducting pediatric virotherapy and immunotherapy brain tumor research. His overarching goal is to improve outcomes for children with malignant brain tumors by developing and improving novel, targeted therapies in the lab and then translating these therapies to clinical trials. Herpes virus (HSV), which typically causes cold sores, has been engineered to be safe for normal cells but can infect and kill cancer cells and stimulate the patient’s own immune system to attack the tumor providing a one- two punch at killing tumor cells. To maximize the benefit of this therapy, his lab focuses on determining mechanisms of therapeutic resistance by exploring the role of tumor genotype, phenotype, and microenvironment; and cellular defense mechanisms so that newer viruses, novel combinations, and unique routes of virus delivery may be developed to circumvent resistance mechanisms. Friedman is the principal investigator for the first- ever pediatric trial of HSV G2. NCT0. 24. 57. 84. Frederick Goldman, M. D. Professor of Pediatrics. Director, Lowder Pediatric Blood and Marrow Transplantation Program. Senior Scientist Immunology & Cancer Immunotherapeutics Program. UAB Comprehensive Cancer Center. Dr. Goldman is a Professor of Pediatrics and Director of the Lowder Blood and Marrow Transplant Program and a member of the Division of Pediatric Hematology- Oncology. Goldman is a graduate of the Louisiana State University School of Medicine. He completed pediatric residency training at Tulane Children's Hospital and fellowship training at Denver Children's Hospital. Goldman's basic science research focuses on understanding the role of a specific enzyme complex called telomerase in cancer, bone marrow production, and aging, and how this enzyme is crucial in minimizing toxicities of chemotherapy. Goldman is involved in studies of new gene transfer methods to treat marrow failure syndromes (Dyskeratosis congenita) and disorders of hematopoiesis (sickle cell disease). Goldman has been recognized for clinical excellence by selection as one of the . Haines obtained her undergraduate degree from Louisiana State University, and is a graduate of Louisiana State University School of Medicine in New Orleans. Haines' clinical interests include supportive care and treatment of viral infections in bone marrow transplant patients and bone marrow transplant for non- malignant disease such as immunodeficiency and sickle cell disease. Lee M. Hilliard, M. D. Professor of Pediatrics. Chair, CHS Blood Utilization Committee. Dr. Hilliard's area of focus is hematology. Hilliard focuses on stroke risk assessment and prevention, health care delivery in rural areas, management of iron overload in chronically transfused patients (including the use of erythrocytapheresis) and the use of hydroxyurea in sickle cell disease. Thomas H. Howard, M. D. Professor of Pediatrics. Director, Hematology Section. Co- Director UAB Comprehensive Sickle Cell Center. Dr. Howard hails from North Carolina, graduated from the University of North Carolina at Chapel Hill in Chemistry, and received his MD degree from the Johns Hopkins University School of Medicine (JHUSOM). Howard's primary clinical interest is general hematology with a focus on sickle cell disease (SCD), hemophilia and red and white blood cell defects. Howard's research career interests and experience include an NIH funded basic research program focused on assembly and regulation of the molecular motor in neutrophils; his clinical research focuses on neurological abnormalities, health care delivery, and novel therapies for SCD. The network, established in 1. SCDAA chapters, hospital and clinics, is an unique, nationally recognized care system and has served Alabamians continuously since its inception. Matthew Kutny, M. D. Assistant Professor of Pediatrics. Dr. Kutny is a graduate of Brown University and Vanderbilt University School of Medicine. He completed training in pediatrics at Vanderbilt University Children’s Hospital. He then trained in Pediatric Hematology/Oncology and Bone Marrow Transplant through the University of Washington at the Fred Hutchinson Cancer Research Center and Seattle Children’s Hospital. Kutny’s clinical practice includes both general hematology and oncology and bone marrow transplant. His research interests focus on the treatment of pediatric leukemia. He is working to improve risk stratification and treatment allocation for patients with acute myeloid leukemia and developing new targeted treatments for relapsed and de novo leukemia. Wendy Landier, Ph. D, R. N. Associate Professor. Dr. Landier is a leader with Dr. Bhatia in defining the key issues of the late effects of childhood cancer therapy. Her research focuses on understanding and improving health outcomes in cancer survivors. She is a Pediatric Nurse Practitioner and also holds a Ph. D in Nursing. She Chairs the Nursing Discipline Committee for the Children’s Oncology Group. She is extensively published with approximately 5. She is well funded as an individual and as an active colleague in Dr. Bhatia’s research program. Landier holds a dual appointment in the School of Nursing where she serves as an important mentor for nursing students. Jeffrey Lebensburger, D. O. Associate Professor of Pediatrics. Dr. Lebensburger is a graduate of the University of Pennsylvania for undergraduate training and the Nova Southeastern Medical School. After his pediatric residency at Arnold Palmer Hospital for Children in Orlando, Florida, Dr. Lebensburger completed fellowship training in Pediatric Hematology Oncology at St. Jude Children's Research Hospital. His primary focus involves children with disorders of the blood, especially sickle cell Disease, thalassemia, disorders of iron metabolism, and marrow failure syndromes including aplastic anemia. His research focuses on linking knowledge from basic science to clinical care (translational research) especially in sickle cell disease. A long term goal of the research is gene therapy for blood disorders. Zachary Le. Blanc, M. D. Instructor. Alyssa Reddy, M. D. Professor of Pediatrics. Director, Neuro- Oncology Program. Dr. Reddy is a Professor of Pediatrics, Neurology, and Surgery at UAB. Reddy received her undergraduate degrees from Boston University and medical degree from UAB. Reddy was instrumental in starting the UAB Pediatric Neuro- Oncology Clinic in 1. US. Reddy's research interests include development and implementation of clinical trials for children with nervous system tumors. Reddy is also the UAB Institution principal investigator for COG as well as several multi- center treatment and cognitive effects studies.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
August 2017
Categories |